These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 26004200)
1. Jump from pre-mutation to pathologic expansion in C9orf72. Xi Z; van Blitterswijk M; Zhang M; McGoldrick P; McLean JR; Yunusova Y; Knock E; Moreno D; Sato C; McKeever PM; Schneider R; Keith J; Petrescu N; Fraser P; Tartaglia MC; Baker MC; Graff-Radford NR; Boylan KB; Dickson DW; Mackenzie IR; Rademakers R; Robertson J; Zinman L; Rogaeva E Am J Hum Genet; 2015 Jun; 96(6):962-70. PubMed ID: 26004200 [TBL] [Abstract][Full Text] [Related]
2. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Xi Z; Zhang M; Bruni AC; Maletta RG; Colao R; Fratta P; Polke JM; Sweeney MG; Mudanohwo E; Nacmias B; Sorbi S; Tartaglia MC; Rainero I; Rubino E; Pinessi L; Galimberti D; Surace EI; McGoldrick P; McKeever P; Moreno D; Sato C; Liang Y; Keith J; Zinman L; Robertson J; Rogaeva E Acta Neuropathol; 2015 May; 129(5):715-27. PubMed ID: 25716178 [TBL] [Abstract][Full Text] [Related]
3. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases. Porta S; Kwong LK; Trojanowski JQ; Lee VM J Neuropathol Exp Neurol; 2015 Apr; 74(4):380-7. PubMed ID: 25756586 [TBL] [Abstract][Full Text] [Related]
4. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Cooper-Knock J; Shaw PJ; Kirby J Acta Neuropathol; 2014 Mar; 127(3):333-45. PubMed ID: 24493408 [TBL] [Abstract][Full Text] [Related]
5. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Vatovec S; Kovanda A; Rogelj B Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899 [TBL] [Abstract][Full Text] [Related]
6. The association between repeat number in C9orf72 and phenotypic variability in Turkish patients with frontotemporal lobar degeneration. Erzurumluoglu E; Cilingir O; Ozbabalik Adapinar BD; Bilgic B; Kocagil S; Ozen H; Durak Aras B; Yenilmez C; Artan S Neurobiol Aging; 2019 Apr; 76():216.e1-216.e7. PubMed ID: 30685122 [TBL] [Abstract][Full Text] [Related]
7. Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Beck J; Poulter M; Hensman D; Rohrer JD; Mahoney CJ; Adamson G; Campbell T; Uphill J; Borg A; Fratta P; Orrell RW; Malaspina A; Rowe J; Brown J; Hodges J; Sidle K; Polke JM; Houlden H; Schott JM; Fox NC; Rossor MN; Tabrizi SJ; Isaacs AM; Hardy J; Warren JD; Collinge J; Mead S Am J Hum Genet; 2013 Mar; 92(3):345-53. PubMed ID: 23434116 [TBL] [Abstract][Full Text] [Related]
8. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854 [TBL] [Abstract][Full Text] [Related]
9. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318 [TBL] [Abstract][Full Text] [Related]
10. Unaffected mosaic McGoldrick P; Zhang M; van Blitterswijk M; Sato C; Moreno D; Xiao S; Zhang AB; McKeever PM; Weichert A; Schneider R; Keith J; Petrucelli L; Rademakers R; Zinman L; Robertson J; Rogaeva E Neurology; 2018 Jan; 90(4):e323-e331. PubMed ID: 29282338 [TBL] [Abstract][Full Text] [Related]
11. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Gijselinck I; Van Langenhove T; van der Zee J; Sleegers K; Philtjens S; Kleinberger G; Janssens J; Bettens K; Van Cauwenberghe C; Pereson S; Engelborghs S; Sieben A; De Jonghe P; Vandenberghe R; Santens P; De Bleecker J; Maes G; Bäumer V; Dillen L; Joris G; Cuijt I; Corsmit E; Elinck E; Van Dongen J; Vermeulen S; Van den Broeck M; Vaerenberg C; Mattheijssens M; Peeters K; Robberecht W; Cras P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C Lancet Neurol; 2012 Jan; 11(1):54-65. PubMed ID: 22154785 [TBL] [Abstract][Full Text] [Related]
12. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860 [TBL] [Abstract][Full Text] [Related]
13. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Waite AJ; Bäumer D; East S; Neal J; Morris HR; Ansorge O; Blake DJ Neurobiol Aging; 2014 Jul; 35(7):1779.e5-1779.e13. PubMed ID: 24559645 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients. Xi Z; Rainero I; Rubino E; Pinessi L; Bruni AC; Maletta RG; Nacmias B; Sorbi S; Galimberti D; Surace EI; Zheng Y; Moreno D; Sato C; Liang Y; Zhou Y; Robertson J; Zinman L; Tartaglia MC; St George-Hyslop P; Rogaeva E Hum Mol Genet; 2014 Nov; 23(21):5630-7. PubMed ID: 24908669 [TBL] [Abstract][Full Text] [Related]
18. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Cruts M; Gijselinck I; Van Langenhove T; van der Zee J; Van Broeckhoven C Trends Neurosci; 2013 Aug; 36(8):450-9. PubMed ID: 23746459 [TBL] [Abstract][Full Text] [Related]
19. Characterization of DNA G-quadruplex species forming from C9ORF72 G4C2-expanded repeats associated with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Šket P; Pohleven J; Kovanda A; Štalekar M; Župunski V; Zalar M; Plavec J; Rogelj B Neurobiol Aging; 2015 Feb; 36(2):1091-6. PubMed ID: 25442110 [TBL] [Abstract][Full Text] [Related]
20. The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues. Woollacott IO; Mead S Acta Neuropathol; 2014 Mar; 127(3):319-32. PubMed ID: 24515836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]